PraxisPro, a data intelligence company focused on transforming the life sciences industry, has announced the successful closing of a $6 million seed round, which was oversubscribed. The funding round was led by AlleyCorp, with significant participation from Flybridge, South Loop Ventures, Zeal Capital Partners, True Ventures, Techstars, Alumni Ventures, and Daring Ventures. The company is building a next-generation platform designed to address the persistent challenges of fragmented, incomplete, and poorly documented data within the life sciences sector. By leveraging artificial intelligence and advanced data integration techniques, PraxisPro aims to deliver actionable commercial intelligence that enables pharmaceutical and biotech organizations to make faster, more informed decisions. Life sciences firms often struggle with siloed data across sales, marketing, medical affairs, and field operations, leading to inefficiencies in strategy, forecasting, and customer engagement. PraxisPro’s solution centralizes and enriches this information, offering real-time insights that improve commercial performance and accelerate time-to-market for new therapies. The company’s founders bring deep expertise in data science, healthcare technology, and commercial strategy, with a mission to modernize how life sciences organizations understand and engage with healthcare providers, payers, and patients. With the new capital, PraxisPro plans to expand its engineering and product teams, enhance its AI-driven analytics platform, and scale customer adoption across the pharmaceutical and biotech industries. The investment underscores growing confidence in AI-powered data solutions as essential tools for competitiveness in an increasingly complex and data-driven healthcare landscape.